Patents by Inventor Haruo Ogura

Haruo Ogura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5126330
    Abstract: The present invention relates to a sodium salt of sialosyl cholesterol. The present compound has an excellent high water solubility, and therefore the compound is very useful as a medicine to be used for treating various diseases derived from lesions of peripheral or central nerves.
    Type: Grant
    Filed: February 1, 1991
    Date of Patent: June 30, 1992
    Assignee: Mect Corporation
    Inventors: Haruo Ogura, Kimio Furuhata, Shingo Sato, Masayoshi Ito, Yoshiyasu Shitori, Yoshitaka Nagai
  • Patent number: 5023239
    Abstract: The present invention relates to a sodium salt of sialosyl cholesterol. The present compound has an excellent high water solubility, and therefore the compound is very useful as a medicine to be used for curing various diseases derived from lesions of peripheral or central nerves.
    Type: Grant
    Filed: January 7, 1988
    Date of Patent: June 11, 1991
    Assignee: MECT Corporation
    Inventors: Haruo Ogura, Kimio Furuhata, Shingo Sato, Masayoshi Ito, Yoshiyasu Shitori, Yoshitaka Nagai
  • Patent number: 4939156
    Abstract: As new compounds are now provided 7,7,8,8,-tetramethyl-cis-diaza-bicyclo{4.2.0}octane-3,5,-dione derivatives which have an activity to induce the differentiation of tumor cells and are useful as antitumor agent, and which also have an antiviral activity against various viruses and are useful as antiviral agent. These new derivatives may be produced by a photo-addition reaction of a uracil compound with 2,3-dimethyl-2-butene.
    Type: Grant
    Filed: July 8, 1988
    Date of Patent: July 3, 1990
    Assignee: Meiji Seika Kaisha, Ltd.
    Inventors: Motoo Hozumi, Tsuneo Itoh, Yoshio Honma, Norio Kawahara, Ichiro Ishikawa, Haruo Ogura
  • Patent number: 4914195
    Abstract: A new process for preparing halides of N-acetylneuraminic acids useful as an intermediate in preparing new N-acetylneuraminic acid derivatives having an excellent immunological activity is provided, which process comprises simultaneously acetylating and halogenating an esterified N-acetylneuraminic acid with the aid of an acetyl halide, and according to the process, the halides may be obtained in high yield of about 90%.
    Type: Grant
    Filed: November 26, 1984
    Date of Patent: April 3, 1990
    Assignee: MECT Corporation
    Inventors: Haruo Ogura, Kimio Furuhata, Yoshiyasu Shitori, Masayoshi Ito
  • Patent number: 4774327
    Abstract: This invention provides a novel compound having the following formula: ##STR1## This compound is a useful intermediate for the preparation of N-glycolylneuraminic acid: ##STR2##
    Type: Grant
    Filed: October 10, 1986
    Date of Patent: September 27, 1988
    Assignee: Mect Corporation
    Inventors: Haruo Ogura, Kimio Furuhata, Masayoshi Ito, Yoshiyasu Shitori
  • Patent number: 4691012
    Abstract: A novel N-acetylneuraminic acid derivative, represented by the general formula: ##STR1## wherein the R.sup.1 groups are, independently, hydrogen or acetyl; R.sup.2 is a nucleoside residue; and R.sup.3 is carboxyl or methoxycarbonyl.The N-acetylneuraminic acid derivative is useful in inhibiting metastasis of cancer cells. Also provided is a process for the preparation of the derivatives.
    Type: Grant
    Filed: March 6, 1985
    Date of Patent: September 1, 1987
    Assignee: MECT Corporation
    Inventors: Haruo Ogura, Kimio Furuhata, Toshiaki Osawa, Satoshi Toyoshima, Yoshiyasu Shitori, Masayoshi Ito, Shoji Yoshimura
  • Patent number: 4447600
    Abstract: Nucleoside or glucose derivatives of N-acetylneuraminic acids are provided, which have immunological activity, are clinically useful, as an immuno suppressive, in particular to treat autoimmune disease such as collagenosis disease without causing any serious side-effects and may be prepared by subjecting a halide of N-acetylneuraminate derivative together with a nucleoside or a glucose to Koenigs-Knorr reaction.
    Type: Grant
    Filed: May 20, 1982
    Date of Patent: May 8, 1984
    Assignee: Kanto Ishi Pharmaceutical Co., Ltd.
    Inventors: Haruo Ogura, Kimio Furuhata, Toshiaki Osawa, Satoshi Toyoshima, Yoshiyasu Shitori, Masayoshi Ito
  • Patent number: 4427768
    Abstract: A method of hardening gelatin is described comprising treating gelatin with a compound of the formula (I) ##STR1## wherein R.sup.1 and R.sup.2 can each represent a monovalent group including a carbon atom or a nitrogen atom forming a bond together with the nitrogen atom N forming an acid ester in the formula (I); or R.sup.1 and R.sup.
    Type: Grant
    Filed: July 2, 1982
    Date of Patent: January 24, 1984
    Assignee: Fuji Photo Film Co., Ltd.
    Inventors: Katuji Kitatani, Hidefumi Sera, Atsuaki Arai, Masasi Ogawa, Kunio Ishigaki, Haruo Ogura
  • Patent number: 4341707
    Abstract: A new carbonate compound which is N,N'-di-succinimidyl carbonate, N,N'-diphthalimidyl carbonate or N,N'-bis(5-norbornene-2,3-dicarboxyimidyl) carbonate is produced by reacting an N-hydroxy compound of the formulaR-OHwherein R is succinimido, phthalimido or 5-norbornene-2,3-dicarboximido group, with a silylating agent, followed by reacting the resultant silylated product with phosgene, or alternatively by reacting said N-hydroxy compound with trichloromethyl chloroformate either in the molten state or in the presence of a non-polar organic solvent such as xylene.
    Type: Grant
    Filed: April 18, 1980
    Date of Patent: July 27, 1982
    Assignee: Haruo Ogura
    Inventors: Haruo Ogura, Kazuyoshi Takeda
  • Patent number: 4025622
    Abstract: Novel sugar ureide and thioureide derivatives are provided by this invention, which exhibit certain antibacterial activity against a variety of gram-positive and gram-negative bacteria and useful in therapeutic treatment of bacterial infections. The compounds have the formula ##STR1## wherein R.sub.1 is a monovalent residue of aldose, aldonic acid and their 2-amino derivatives, R.sub.2 is an aralkyl, heterocyclic, sulfamoylaryl, R.sub.3 CONH or R.sub.4 NH-- where R.sub.3 is a heterocyclic and R.sub.4 is an aryl group and Y is oxygen or sulfur atom, which are prepared by reacting an isocyanate or isothiocyanate of the formula R.sub.1 NC=Y with an amino compound of the formula R.sub.2 NH.sub.2.
    Type: Grant
    Filed: February 26, 1975
    Date of Patent: May 24, 1977
    Assignee: Haruo Ogura
    Inventors: Haruo Ogura, Hiroshi Takahashi